SAA1 and Alzheimer disease: SAA immunoreactivity co-localized with Aβ deposits in AD brain (Kindy et al., 1999), and SAA concentration was much higher in cerebrospinal fluid (CSF) of AD subjects than in normal controls (Miida et al., 2006).